Literature DB >> 19439965

Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.

Ruth Vukovich1, Robert Perneczky, Alexander Drzezga, Hans Förstl, Alexander Kurz, Matthias Riemenschneider.   

Abstract

BACKGROUND: The cerebrospinal fluid (CSF) proteins beta-amyloid 42 (Abeta42) and Tau are believed to indirectly reflect some core pathological features of Alzheimer's disease (AD). Their topographic origin and their association with synaptic dysfunction are still not well understood. AIM: The present study aimed to explore possible associations between cerebral glucose metabolism and CSF Abeta42 as well as Tau protein levels in AD.
METHODS: CSF analyses and (18)F-FDG PET scans were conducted on 32 patients with mild-to-moderate AD. Voxel-based statistical parametric correlations were computed for CSF protein levels and cerebral glucose metabolism.
RESULTS: After correction for multiple comparisons, a strong positive association between CSF Abeta42 levels and glucose metabolism was identified for 2 extensive clusters located in the right temporal, prefrontal and anterior cingulate cortices. For CSF Tau protein, no association was observed for any brain region.
CONCLUSIONS: These findings point to a significant association between synaptic dysfunction as measured with (18)F-FDG PET and CSF Abeta42 levels, but do not suggest a correlation between synaptic function and CSF Tau levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439965     DOI: 10.1159/000218080

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  6 in total

1.  Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain.

Authors:  Agostino Chiaravalloti; Anna Elisa Castellano; Maria Ricci; Gaetano Barbagallo; Pasqualina Sannino; Francesco Ursini; Georgios Karalis; Orazio Schillaci
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

2.  The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease.

Authors:  Alice Jaillard; Matthieu Vanhoutte; Aurélien Maureille; Susanna Schraen; Emilie Skrobala; Xavier Delbeuck; Adeline Rollin-Sillaire; Florence Pasquier; Stéphanie Bombois; Franck Semah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-28       Impact factor: 9.236

3.  Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer's disease.

Authors:  Marie-Odile Habert; Leonardo Cruz de Souza; Foudil Lamari; Nelle Daragon; Serge Desarnaud; Claude Jardel; Bruno Dubois; Marie Sarazin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

4.  The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.

Authors:  Jeffrey Cummings
Journal:  Alzheimers Dement       Date:  2018-06-21       Impact factor: 21.566

5.  Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.

Authors:  Ina S Almdahl; Camilla Lauridsen; Per Selnes; Lisa F Kalheim; Christopher Coello; Beata Gajdzik; Ina Møller; Marianne Wettergreen; Ramune Grambaite; Atle Bjørnerud; Geir Bråthen; Sigrid B Sando; Linda R White; Tormod Fladby
Journal:  Front Aging Neurosci       Date:  2017-02-07       Impact factor: 5.750

6.  Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.

Authors:  Stefan L C Geijselaers; Pauline Aalten; Inez H G B Ramakers; Peter Paul De Deyn; Annemieke C Heijboer; Huiberdina L Koek; Marcel G M OldeRikkert; Janne M Papma; Fransje E Reesink; Lieke L Smits; Coen D A Stehouwer; Charlotte E Teunissen; Frans R J Verhey; Wiesje M van der Flier; Geert Jan Biessels
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.